Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen
Clinical trial NCT04839965 · TERMINATED
Trial details
- NCT number
- NCT04839965
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2022-02-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.